zonisamide has been researched along with Pulmonary Eosinophilia in 1 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
Pulmonary Eosinophilia: A condition characterized by infiltration of the lung with EOSINOPHILS due to inflammation or other disease processes. Major eosinophilic lung diseases are the eosinophilic pneumonias caused by infections, allergens, or toxic agents.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shibuya, R | 1 |
| Tanizaki, H | 1 |
| Nakajima, S | 1 |
| Koyanagi, I | 1 |
| Kataoka, TR | 1 |
| Miyachi, Y | 1 |
| Kabashima, K | 1 |
1 other study available for zonisamide and Pulmonary Eosinophilia
| Article | Year |
|---|---|
DIHS/DRESS with remarkable eosinophilic pneumonia caused by zonisamide.
Topics: Adrenal Cortex Hormones; Biopsy; Drug Hypersensitivity Syndrome; Female; Humans; Isoxazoles; Middle | 2015 |